Alyeska Investment Group
FLXN

Alyeska Investment Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Alyeska Investment Group’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-250,000
Closed -$4.75M – 581
2016
Q4 		$4.75M Buy
+250,000
New +$4.78M 0.04% 327

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Alyeska Investment Group's FLXN Position: Q1 2017 in Review

Alyeska Investment Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2017, closing a stake of 250,000 shares — an estimated $4.75M sold.

Alyeska Investment Group first reported a position in FLXN in Q4 2016 and held it in 1 quarter. The position peaked at $4.75M in Q4 2016. 100 funds tracked by Wall St. Rank hold FLXN as of Q1 2017.

  • Alyeska Investment Group reported no remaining Flexion Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Alyeska Investment Group sold 250,000 Flexion Therapeutics, Inc. shares in Q1 2017, an estimated $4.75M.
  • Alyeska Investment Group first reported a position in Flexion Therapeutics, Inc. in Q4 2016 and held it in 1 quarter.
  • Alyeska Investment Group's Flexion Therapeutics, Inc. position peaked at $4.75M in Q4 2016.
  • 100 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2017.

Based on Alyeska Investment Group's 13F filing for Q1 2017, filed 15 May 2017.